Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase-4 Inhibitors

Dipeptidyl peptidase-4 inhibitors (DPP-4i) are useful incretin-based antidiabetes drugs. However, there is a concern that DPP-4i may adversely impact the exocrine pancreas, owing to their pleiotropic effects. In this study, we investigated whether DPP-4i are associated with pancreatitis and pancreat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2019-11, Vol.42 (11), p.2057-2064
Hauptverfasser:	Lee, Minyoung, Sun, Jiyu, Han, Minkyung, Cho, Yongin, Lee, Ji-Yeon, Nam, Chung Mo, Kang, Eun Seok
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Drugs Exposure Health hazards Health risk assessment Health risks Inhibitors Lag time Latency Medical diagnosis Medical screening Pancreas Pancreatic cancer Pancreatitis Peptidase Population studies Research design Risk Statistical models Time dependence Trends
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!